The PI3K/mTOR Pathway Is Targeted by Rare Germline Variants in Patients with Both Melanoma and Renal Cell Carcinoma
| Description | |
| Date de publication | |
| Auteurs | Hubert JN, Suybeng V, Vallee M, Delhomme TM, Maubec E, Boland A, Bacq D, Deleuze JF, Jouenne F, Brennan P, McKay JD, Avril MF, Bressac-de Paillerets B and Chanudet E |
| Revue | |
| Année | 2,021 |
| Département / Service | |
| Laboratoire | |
| Impact Factor | 6.64 |
| Institut | JACOB |
| url DOI | 10.3390/cancers13092243 |